DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
US Stock MarketDetailed Quotes
PHAR Pharming Group
- 9.890
- -0.570-5.45%
Close Jan 3 16:00 ET
670.89MMarket Cap-36.63P/E (TTM)
10.230High9.890Low5.48KVolume10.230Open10.460Pre Close54.74KTurnover0.01%Turnover RatioLossP/E (Static)67.84MShares13.20052wk High2.97P/B649.35MFloat Cap6.65052wk Low--Dividend TTM65.66MShs Float21.990Historical High--Div YieldTTM3.25%Amplitude6.100Historical Low9.986Avg Price1Lot Size
Pharming Group News
Pharming Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)
H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
RBC Capital Remains a Buy on Pharming Group (PHGUF)
H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and GE Healthcare Technologies Inc (GEHC)
Critical Insights From Pharming Analyst Ratings: What You Need To Know
Pharming Analyst Ratings
Jefferies Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $14
Pharming Group Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $30
Pharming Analyst Ratings
H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)
Pharming Analyst Ratings
H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
Buy Rating Affirmed for Pharming Group on Leniolisib's Progress and Joenja's Market Expansion
Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $31
Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)